Last refreshed: July 15, 2026 (Wednesday Evening / PM refresh) · Auto: daily.
Iran Day 140 — O4 CRITICAL — Blockade Reinstated: Hormuz blockade holds — 2 tankers struck Jul 14, dark transits penalized, 503 vessels stopped/anchored. ~34 transits/day (vs 88 norm). Trump proposed 20% Hormuz toll Jul 15, scrapped within 24h. Section 232 pharma tariffs T-16 (Jul 31 — 100% branded-pharma duty). GL X wind-down Jul-17 (T-2). Iranian cyber watch day 7 — no confirmed healthcare intrusion. Mediation active (Qatar in Tehran, Araghchi in Oman). Convergence risk: kinetic freight disruption + tariff deadline + elevated Iranian cyber peaking in same 2-week window.
Medline Tracy DC Fire — Day 34 — O2 ELEVATED: Recovery phase. 1.6M+ sq ft replacement space secured (925K Tracy Sugar Rd + 709K Stockton). 45% NorCal expansion. Supply chain stabilizing — Kaiser unaffected, Sutter minimal, John Muir & Stanford improving. ~1,000 employees returned. MDLN $40.29 (+21% from low). Lawsuit filed. 660+ properties cleaned. Medline convenience kits (ChloraPrep/FREPP) 970+ lots FDA early alert — sterility failure, Class I escalation candidate.
Ebola Bundibugyo O4 CRITICAL: DRC 906 suspected / 105 confirmed / 223 suspected deaths / 10 confirmed deaths. Outbreak spread to Butembo (North Kivu). Uganda 7 confirmed / 1 death. HHS §319 PHE probability materially elevated. Airport screening JFK/EWR/IAD/ATL/ORD. No FDA-approved vaccine for Bundibugyo strain.
Healthcare cyber threat level ELEVATED — Iranian watch day 7: 223 incidents tracked (rev 68). Exact Sciences Corp breach (ShinyHunters, O3, deadline Jul 18). Aphena Pharma Solutions (Chaos, supply-chain node). 31+ concurrent extortion actors. H1 2026: 410 attacks globally, 2.3/day (+14% vs H2 2025). Iranian cyber watch day 7 — no confirmed healthcare intrusion but retaliatory probability remains at peak.
FDA Recalls: 197 active items, 55 Class I (rev 121). Key: Medtronic Harmony DCS Class I (structural heart), Baxter Volara Class I escalation (respiratory). EO Watch: 43 EOs YTD, 18 trade/supply-chain (rev 119). Section 232 pharma tariffs Jul 31 (T-16). Signed-but-unposted Jul 13 EO in pipeline.